Amgen in the news
ShareCopied to clipboardAnalyze the latest Amgen news, with a current neutral sentiment polarity (0.11) or the entire set.
Latest news
Here are the latest news on this scope:
Amgen starts two critical late-stage trials for weight loss drug MariTide
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup
Ozempic competitor in the works at Amgen reaches late-stage clinical trials
Amgen just got one step closer to bringing its Ozempic competitor to market
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Stocks making the biggest moves premarket: Amgen, Best Buy, Abercrombie & Fitch, Stellantis and more
Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed
Amgen says no concerns around weight loss drug's bone density data after stock falls
Stocks making the biggest moves midday: Rivian, Cava, Rocket Lab, Amgen and more
Amgen to open new tech and innovation center in Hyderabad by end of 2024
Stocks making the biggest moves premarket: Disney, Airbnb, Rivian, Amgen and more
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Amgen teased trial results for its potential Ozempic competitor -- and the stock surged 13%
Stocks making the biggest moves premarket: Apple, Amgen, Cloudflare and more
Extract data
Extract all the news on this scope:
Visualize data
Here are some available charts on these news:
Evolution through time
Distribution of sources in the news
Distribution of sections in the news
Sentiment polarity through time